Showing 101 - 110 of 1,916
Pay-What-You-Want (PWYW) is a participative pricing mechanism which is characterizedby the fact that consumers have maximum control over the price they pay. We discuss thebusiness relevance of PWYW and extend the findings of Kim et al. (2009) using latentclass regression. Two different classes...
Persistent link: https://www.econbiz.de/10009418711
Fierce competition and rapid technological progress have considerablyreduced the life cycle length for mobile phones in the last decade. Once a newmobile phone is launched, providers on the market under consideration practice amarkdown strategy. Profits of the providers are generated mainly via...
Persistent link: https://www.econbiz.de/10009360498
In this paper we first show that the gains achievable by integrating pricing and inventory controlare usually small for classical demand functions. We then introduce reference price models anddemonstrate that for this class of demand functions the benefits of integration with inventory...
Persistent link: https://www.econbiz.de/10005858610
In this paper we estimate and empirically test different behavioral theories of consumer reference price formation. Two major theories are proposed to model the reference price reaction: assimilation contrast theory and prospect theory. We assume that different consumer segments will use...
Persistent link: https://www.econbiz.de/10005861848
This paper studies the effect of two regulatory instruments - a price cap and a reference price system - a mandatory substitution rule, and the combination of both on generic competition in a Salop-type model with an off-patent brand-name drug and n differentiated generic versions. The price cap...
Persistent link: https://www.econbiz.de/10010510801
Persistent link: https://www.econbiz.de/10010517015
Persistent link: https://www.econbiz.de/10011313581
Persistent link: https://www.econbiz.de/10010526404
This paper analyzes a maximum price system and a reference price system in a vertical differentiation model with a brand-name drug and a generic. In particular, both instruments are compared with respect to their performance in reducing public expenditure, limiting financial exposure of...
Persistent link: https://www.econbiz.de/10010224844
Persistent link: https://www.econbiz.de/10010225104